BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Fredun Pharmaceuticals Ltd Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
539730
ISIN Demat
INE194R01017
Book Value (Rs)
163.1433353
NSE Symbol
N.A
Divident Yield %
0.02
Market Cap
(Rs In Cr.)
1,533
P/E (TTM)
46.15
EPS (TTM)
20.08
Face Value
(Rs)
10
Back
Fredun Pharmaceuticals standalone net profit rises 96.62% in the December 2025 quarter
13-Feb-26   Hrs IST

Net profit of Fredun Pharmaceuticals rose 96.62% to Rs 10.48 crore in the quarter ended December 2025 as against Rs 5.33 crore during the previous quarter ended December 2024. Sales rose 57.04% to Rs 159.93 crore in the quarter ended December 2025 as against Rs 101.84 crore during the previous quarter ended December 2024.

ParticularsQuarter Ended
Dec. 2025Dec. 2024% Var.
Sales159.93101.84 57
OPM %16.4612.98 -
PBDT15.788.22 92
PBT14.007.13 96
NP10.485.33 97

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed and Maintained by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)